Add BrightSurf on Google Email

Research heralds new era for genetics

The study analyzed the genetic profiles of 80,000 people and found that repeat expansion disorders (REDs) are common across different populations. The findings suggest a significant shift in how we think about genetic testing, profiling, and counseling for these conditions.

SourceQueen Mary University of London·JournalNature Medicine·TypeObservational study·DateOct 1, 2024

Distant relatedness in biobanks harnessed to identify undiagnosed genetic disease

A new method using shared segments within the genome has identified undiagnosed cases of Long QT syndrome, a rare disorder that can lead to abnormal heart rhythms and sudden cardiac death. The approach was developed by researchers at Vanderbilt University Medical Center and applied to a DNA biobank to detect carriers of rare disease-ca...

SourceVanderbilt University Medical Center·JournalNature Communications·TypeData/statistical analysis·DateSep 27, 2024

World's first individual gene mutation test for predicting risk of sudden cardiac death

A new individualized risk prediction tool has been developed to predict the severity of heart disease in people suffering from Long QT syndrome. The test analyzes genetic mutations associated with the condition and can identify those at high risk of sudden cardiac death, allowing for tailored treatment.

SourceVictor Chang Cardiac Research Institute·JournalCirculation·TypeData/statistical analysis·DateSep 25, 2024

New four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke establishes the Mount Sinai Center for Undiagnosed Diseases

The new center aims to provide state-of-the-art genomic services to patients with difficult-to-diagnose diseases, aiming to shed light on undiagnosed conditions and uncover rare variations of more common diseases. The grant will enable the provision of advanced diagnostic services to alleviate the burden of these disorders.

Gene therapy effective in hereditary blindness

Researchers at Karolinska Institutet successfully used gene therapy to improve vision in 11 out of 12 patients with Bothnia dystrophy, a form of hereditary blindness. The treatment involved injecting a specially designed virus under the retina, which produced normal protein and restored visual function.

SourceKarolinska Institutet·JournalNature Communications·DateSep 10, 2024

Children’s Hospital of Philadelphia researchers report encouraging first evidence of effective new gene therapy to treat multiple sulfatase deficiency

Children's Hospital of Philadelphia researchers have reported encouraging evidence of an effective new gene therapy to treat multiple sulfatase deficiency. The ex vivo gene therapy improved sulfatase production and reduced symptoms associated with the disease in preclinical models.

SourceChildren's Hospital of Philadelphia·JournalMolecular Therapy·TypeExperimental study·DateSep 9, 2024

Solving the side effect problem of siRNA drugs for genetic disease treatment using formamide

Researchers at Nagoya University have developed a method to chemically alter siRNAs, reducing off-target effects and improving the safety of siRNA drugs for genetic therapy. By modifying the seed region of siRNAs with formamide, they achieved suppression of off-target effects with higher efficiency than existing chemical modifications.

SourceNagoya University·JournalNucleic Acids Research·DateSep 6, 2024

Does low lipoprotein(a) increase the risk of diabetes? New research suggests it does not

Researchers used genetic method Mendelian randomization to show high levels of fasting insulin cause reduction in Lp(a), rather than the other way around. Low Lp(a) is unlikely to be a risk factor for type 2 diabetes, independent of pre-existing hyperinsulinaemia and insulin resistance.

SourcePolskie Towarzystwo Lipidologiczne (Polish Lipid Association)·JournalCardiovascular Diabetology·TypeData/statistical analysis·DateAug 29, 2024

Gene therapy gets a turbo boost from University of Hawaii researchers

Researchers at the University of Hawaii have developed a new gene editing technology that can efficiently deliver healthy genes to the body. This method addresses limitations of current methods and has shown success rates of up to 96%, potentially leading to faster and more affordable treatments for various genetic diseases.

SourceUniversity of Hawaii at Manoa·JournalNucleic Acids Research·TypeExperimental study·DateAug 29, 2024

‘Silent’ mutations found to have repercussions beyond their own gene

Silent gene mutations may have significant consequences beyond their own gene, according to a study published in the Proceedings of the National Academy of Sciences. Researchers found that synonymous mutations in one gene can increase the production of a neighboring gene by recruiting RNA polymerase to cryptic transcription sites.

SourceUniversity of Notre Dame·JournalProceedings of the National Academy of Sciences·DateAug 28, 2024

UVA research cracks the autism code, making the neurodivergent brain visible

A multi-university research team led by University of Virginia engineering professor Gustavo K. Rohde has developed a system that can accurately spot genetic markers of autism in brain images. The system uses generative computer modeling technique called transport-based morphometry, which reveals brain structure patterns that predict v...

Chronic cough may be hereditary

A study published at Uppsala University found that chronic cough is hereditary, with a 50% increased risk for offspring if one parent has the condition. The research also revealed differences in care between regions and highlights the need for better guidelines.

SourceUppsala University·JournalERJ Open Research·TypeObservational study·DateAug 22, 2024

ECU medical researchers confirm genetic link between Alzheimer’s and heart disease

Researchers at Edith Cowan University have uncovered a significant genetic connection between Alzheimer's disease and several coronary artery disease-related disorders, offering opportunities to improve health outcomes. The study found that some of the same genes played a role in or are associated across these conditions.

SourceEdith Cowan University·JournalInternational Journal of Molecular Sciences·TypeMeta-analysis·DateAug 15, 2024

World first discoveries allow researchers to accurately diagnose prenatal exposure syndromes and birth disorders

Researchers at Lawson Health Research Institute have made a world-first discovery using advanced technology and artificial intelligence (AI) to accurately diagnose rare diseases and prenatal exposure-related birth abnormalities. They used EpiSign technology, which measures a patient's epigenome, to identify patients affected by recurre...

SourceLawson Health Research Institute·JournalAmerican Journal of Human Genetics·DateJul 31, 2024

Published research from the Parkinson’s Foundation shows genetic variants are more common in people with Parkinson’s disease than originally thought

The PD GENEration study has found that 13% of participants have a genetic form of Parkinson's disease, significantly higher than previous estimates. The study, which reached its goal of 15,000 participants ahead of schedule, provides insights into the genetics of the disease and its potential for precision medicine.

SourceParkinson's Foundation·JournalBrain·TypeObservational study·DateJul 29, 2024

Large genetic study on severe COVID-19

Researchers found that mutations in the TLR7 gene significantly increase the risk of severe COVID-19, as well as changes in the TBK1, INFAR1, and IFIH1 genes. The study also suggests gender-specific differences in how genetic factors influence disease progression.

SourceUniversitatsklinikum Bonn·JournalHuman Genetics and Genomics Advances·DateJul 24, 2024

New NIPT-based method reveals 33 pathogenic CNVs in the DMD gene

Researchers developed a new NIPT-based method that reveals 33 pathogenic copy number variations (CNVs) in the Duchenne muscular dystrophy (DMD) gene. This study provides valuable insights into the frequency and spectrum of maternal CNV carriers in the Chinese population.

SourceBGI Genomics·JournalClinical and Translational Medicine·TypeData/statistical analysis·DateJul 17, 2024

Correcting mutations that cause stroke

LMU researchers have developed strategies to repair mutated proteins that cause an inherited stroke disorder called CARASIL. The team used a combination of in-vitro and in-vivo methods to restore the function of the protease HTRA1, which plays a crucial role in maintaining equilibrium in the extracellular matrix.

SourceLudwig-Maximilians-Universität München·JournalNature Communications·TypeExperimental study·DateJul 16, 2024

Study reveals racial disparities in Huntington’s disease diagnoses

A new study by UCLA Health reveals racial disparities in Huntington's disease diagnoses, with Black patients receiving diagnoses one year later than White patients. The study analyzed nearly 5,000 patient data points and found that these disparities may exacerbate underrepresentation of minority groups in clinical trials.

SourceUniversity of California - Los Angeles Health Sciences·JournalNeurology Clinical Practice·TypeData/statistical analysis·DateJul 9, 2024

Researchers evaluate the benefit of dual therapy for children at risk for spinal muscular atrophy

A first-of-its-kind study compared preventative therapy efficacy between two groups: gene therapy alone and in combination with risdiplam or nusinersen. Dual therapy showed promise in independent sitting outcomes, but not in walking age or muscle disease progression prevention.

SourceClinic for Special Children·JournalAnnals of Clinical and Translational Neurology·TypeObservational study·DateJun 25, 2024

New cellular models of myotonic dystrophy type 1 reflect the clinical diversity of the disease

Researchers have developed three new cellular models of myotonic dystrophy type 1 that accurately represent the clinical diversity of the disease. The models show great heterogeneity in genetic expansion and molecular alterations, making them suitable for studying pathophysiology and testing therapeutic options.

SourceGermans Trias i Pujol Research Institute·JournaliScience·TypeExperimental study·DateJun 20, 2024

Exercise lifts mood for adults with Down’s syndrome

A new study found that physical activity and cognitive training can improve life satisfaction and mood for adults with Down’s syndrome. The Mindsets study involved 83 participants who were assigned to one of four groups for an eight-week period, including a control group, light physical exercise, or BrainHQ activities.

SourceAnglia Ruskin University·JournalInternational Journal of Environmental Research and Public Health·DateJun 13, 2024

Shedding light on the state of genetic counseling for hereditary transthyretin-related amyloidosis

A retrospective study of 202 participants found that only 83 presymptomatic carriers underwent predictive testing, highlighting limitations in current genetic testing methods. The researchers advocate for a comprehensive clinical approach combining genetic counseling, predictive testing, and monitoring, as well as psychosocial support.

SourceShinshu University·JournalAmyloid·TypeData/statistical analysis·DateJun 13, 2024

Shedding light on the origin of a genetic variant underlying fungal infections

A recent study by Tokyo Medical and Dental University researchers suggests that a specific variant of the CARD9 gene prevalent across northern China, Korea, and Japan may have originated from a common ancestor. The c.820dup variant was found to be relatively common in China and has been estimated to be between 2,000 and 4,000 years old...

SourceTokyo Medical and Dental University·JournalJournal of Clinical Immunology·DateJun 11, 2024

The body’s own lipids affect mental disorders: Can specific inhibitors help?

Research suggests that altered lipid signaling in brain cells contributes to mental disorders, with specific inhibitors showing promise in rebalancing this mechanism. The study found similar changes in both human patients and healthy relatives, as well as mice with genetic disorders, opening up new treatment opportunities.

SourceUniversity of Cologne·JournalMolecular Psychiatry·TypeExperimental study·DateJun 6, 2024

Researchers identify a genetic cause of intellectual disability affecting tens of thousands

Researchers identified a genetic cause of intellectual disability, caused by mutations in the non-coding gene RNU4-2, which affects tens of thousands of people worldwide. The discovery is significant, as it represents one of the most common single-gene genetic causes of neurodevelopmental disorders.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Medicine·TypeData/statistical analysis·DateMay 31, 2024